BlackRock Institutional Trust’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$15.4M	Buy	459,134 +68,446	+18%	+$1.96M	﹤0.01%	2150
2016 Q3	$10.4M	Buy	390,688 +14,440	+4%	+$335K	﹤0.01%	2311
2016 Q2	$8.3M	Buy	376,248 +2,052	+0.5%	+$53.7K	﹤0.01%	2402
2016 Q1	$11M	Sell	374,196 -120	-0%	-$3.34K	﹤0.01%	2202
2015 Q4	$12.4M	Sell	374,316 -21,267	-5%	-$693K	﹤0.01%	2193
2015 Q3	$14.3M	Buy	395,583 +40,692	+11%	+$1.75M	﹤0.01%	2070
2015 Q2	$16M	Buy	354,891 +30,246	+9%	+$1.18M	﹤0.01%	2079
2015 Q1	$9.94M	Buy	324,645 +155,786	+92%	+$6.06M	﹤0.01%	2393
2014 Q4	$8.59M	Buy	168,859 +16,309	+11%	+$730K	﹤0.01%	2449
2014 Q3	$6.04M	Buy	152,550 +36,386	+31%	+$1.45M	﹤0.01%	2604
2014 Q2	$5M	Buy	116,164 +75,915	+189%	+$2.9M	﹤0.01%	2792
2014 Q1	$1.61M	Sell	40,249 -12,742	-24%	-$463K	﹤0.01%	3258
2013 Q4	$1.45M	Sell	52,991 -28,935	-35%	-$701K	﹤0.01%	3275
2013 Q3	$1.88M	Sell	81,926 -101,707	-55%	-$1.94M	﹤0.01%	3156
2013 Q2	$3.25M	Buy	+183,633	New	+$3.58M	﹤0.01%	2883